Procter & Gamble Hygiene and Health Care Limited Earnings Summary — Q1 FY2027
P&G Hygiene and Health Care Records Consistent Performance Amid Sector Stability
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue declined 5.3% sequentially in Q1 FY2027.
- Revenue of ₹891 Cr is 4.9% lower year-on-year.
- Revenue has compounded at -5.1% annualised over the last 10 quarters.
- Net profit of ₹126 Cr is 34.3% below the same quarter last year.
- Profit growth is trailing revenue growth this quarter.
- Net profit has compounded at -8.5% annualised across the period.
- Operating margin stands at 19.1% in Q1 FY2027.
- Operating margin compressed by 933 bps year-on-year.
- Over the last two years operating margin has expanded by 638 bps.
- PBT margin is 19.0%.
- Expenses grew 7.5% against revenue growth of -4.9%.
- Operating profit of ₹170 Cr is 36.1% lower year-on-year.
- Operating leverage has been under pressure recently.
- 3 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 35/100 (Weak) on the latest 10 quarters.
- Business momentum has softened and warrants monitoring.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Stable | 891 | 941 | 1,262 | 1,150 | 937 | 992 | 1,248 | 1,135 | 932 | 1,002 |
| Expenses | Stable | 721 | 723 | 860 | 865 | 671 | 782 | 877 | 845 | 813 | 745 |
| Operating Profit | Volatile | 170 | 218 | 402 | 285 | 266 | 210 | 371 | 290 | 118 | 257 |
| Operating Margin | Improving | 19.1% | 23.2% | 31.8% | 24.8% | 28.4% | 21.1% | 29.7% | 25.6% | 12.7% | 25.7% |
| Other Income | Improving | 9 | 12 | 12 | 10 | 8 | 19 | 10 | 9 | 7 | 14 |
| Interest | Improving | 0 | 3 | 3 | 4 | 0 | 6 | 7 | 2 | -0 | 22 |
| Depreciation | Softening | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 12 | 13 | 15 |
| Profit Before Tax | Volatile | 170 | 218 | 402 | 282 | 265 | 213 | 364 | 285 | 112 | 234 |
| Tax | Volatile | 43 | 65 | 101 | 72 | 73 | 57 | 96 | 73 | 31 | 80 |
| Net Profit | Volatile | 126 | 153 | 301 | 210 | 192 | 156 | 269 | 212 | 81 | 154 |
| Net Margin | Volatile | 14.2% | 16.3% | 23.9% | 18.3% | 20.5% | 15.7% | 21.5% | 18.7% | 8.7% | 15.4% |
Key Takeaways
- P&G Hygiene and Health Care continues to maintain its dominant competitive position in the Feminine Hygiene (Whisper) and Healthcare (Vicks) segments.
- The company operates a debt-free balance sheet, characterized by exceptional capital efficiency and high ROCE/ROE metrics.
- FII shareholding has shown a consistent declining trend, dropping from 1.57% in Mar 2024 to 0.97% by Mar 2026.
- The business model remains asset-light, relying on superior brand equity and a strong, global parent supply chain.
- Margins are historically sensitive to input cost volatility in pulp and petroleum-linked raw materials.
- Dividend payout remains a core part of the capital allocation strategy, supported by strong free cash flow generation.
Management Guidance
Management remains focused on 'balanced growth,' emphasizing premiumization and productivity savings to offset inflationary pressures in raw materials.
Sentiment Shift
Stable
Despite slight declines in foreign institutional ownership, the company's market leadership and operational efficiency remains undisputed.
Outlook
The outlook remains healthy driven by high penetration potential in the sanitary napkin segment and continued strength in the Vicks franchise, though high royalty and input costs remain monitoring points.
From the Annual Report (Key Quotes)
“Consistent premiumization and category leadership despite intense competition.”
“Fortress-like balance sheet capable of weathering any economic downturn.”
“Focus on productivity and cost-optimization programs to offset input cost pressures.”
Official Quarterly Documents
This summary is AI-generated from Procter & Gamble Hygiene and Health Care Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.
← Back to Procter & Gamble Hygiene and Health Care Limited AI analysis